Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

105.20 -0.50 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,392,448
Open 106.29
Bid (Size) 105.22 (800)
Ask (Size) 107.85 (100)
Prev. Close 105.70
Today's Range 103.02 - 106.43
52wk Range 53.56 - 106.47
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
From Incyte
Via Business Wire
Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings?
The past six months have been a windfall for Incyte’s shareholders. The company’s stock price has jumped 78.7%, setting a new 52-week high of $106.50 per share. This was partly due to its solid... 
Via StockStory

Performance

YTD
+51.3%
+51.3%
1 Month
+20.7%
+20.7%
3 Month
+34.5%
+34.5%
6 Month
+76.1%
+76.1%
1 Year
+30.0%
+30.0%

More News

Read More
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Earnings Scheduled For October 28, 2025
Via Benzinga
Exploring Incyte's Earnings Expectations
Via Benzinga
The 5 Most Interesting Analyst Questions From Incyte’s Q3 Earnings Call
Via StockStory
Topics Earnings
Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday
Via Benzinga
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
From Incyte
Via Business Wire
Incyte to Present at Upcoming Investor Conferences
From Incyte
Via Business Wire
INCY Q3 Deep Dive: Strong Product Momentum and Pipeline Reshaping Amid Strategic Refocus
Via StockStory
Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms
Via Benzinga
Topics Intellectual Property
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
Via Benzinga
Topics Economy
Why Incyte (INCY) Stock Is Trading Lower Today
Via StockStory
Incyte (INCY) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Incyte Falls After Hiked 2025 Outlook Misses Wall Street's Bullish Views
Via Investor's Business Daily
Topics Government
Incyte Corp (NASDAQ:INCY) Reports Strong Q3 2025 Earnings, Beating Estimates
Via Chartmill
Topics Earnings
Incyte (NASDAQ:INCY) Reports Strong Q3
Via StockStory
Topics Artificial Intelligence
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Incyte
Via Business Wire
Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System
From Incyte and Enable Injections
Via Business Wire
What To Expect From Incyte’s (INCY) Q3 Earnings
Via StockStory
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic Dermatitis
From Incyte
Via Business Wire

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 105.20
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 23.40B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 23B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.